Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BMS-777607 |
Trade Name | |
Synonyms | ASLAN002|BMS777607|BMS 777607 |
Drug Descriptions |
BMS-777607 (ASLAN002) is a small molecule that inhibits MET, MST1R (RON), TYRO3, and AXL, resulting in decreased downstream pathway activation, potentially resulting in decreased tumor cell growth and metastasis (PMID: 19260711, PMID: 20515943, PMID: 24233399, PMID: 26555154). |
DrugClasses | AXL Inhibitor 30 MET Inhibitor 59 RON Inhibitor 11 TYRO3 Inhibitor 7 |
CAS Registry Number | 1025720-94-8 |
NCIT ID | C74060 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-777607 | BMS-777607 | 0 | 0 |
BMS-777607 + Buparlisib | BMS-777607 Buparlisib | 0 | 0 |
BMS-777607 + Trametinib | BMS-777607 Trametinib | 0 | 0 |